Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes

Published:2014-02 Issue:2 Volume:25 Page:447-454
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Efficace F.,Gaidano G.,Sprangers M.,Cottone F.,Breccia M.,Voso M.T.,Caocci G.,Stauder R.,Di Tucci A.A.,Sanpaolo G.,Selleslag D.,Angelucci E.,Platzbecker U.,Mandelli F.

Funder

‘Associazione Italiana contro le Leucemie, Linfomi e Mieloma (AIL)’

‘Italian Group for Adult Hematologic Diseases (GIMEMA)’

European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/2/447/16699651/mdt557.pdf

Reference28 articles.

1. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches;Deschler;Haematologica,2006

2. NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes;Greenberg;J Natl Compr Canc Netw,2011

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

5. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients;Stauder;Ann Hematol,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic awareness and prognostic information preferences among advanced cancer patients in Kenya;African Journal of Primary Health Care & Family Medicine;2024-04-11

2. Prognostic Awareness, Preferences for Prognostic Information, and Health-related Quality of Life Among Advanced Cancer Patients in Kenya;2023-06-23

3. The Effects of Tyrosine Kinase Inhibitors (TKIs) in Monotherapy and with Add-on Treatments on Health-related Quality of Life of People with Chronic Myeloid Leukemia: A Systematic Review of Randomized-Controlled Trials;Clinical Practice & Epidemiology in Mental Health;2023-01-05

4. Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2022-09

5. Clinicians' Understanding of Preferences and Values of People with Hematological Malignancies at the End of Life: Concurrent Surveys;Journal of Palliative Medicine;2022-09-01